VOLATILE ORGANIC COMPOUNDS FOR INHIBITING FUNGAL GROWTH
Compositions, devices, and methods are disclosed for treating or preventing fungal infection in an animal are provided. The methods involve exposing the animal to one or more volatile organic compounds (VOCs) in a quantity sufficient to inhibit or reduce fungal growth in the animal. Also disclosed is an automated aerosolization unit (AAU) for delivering compositions, such as the disclosed VOCs, to areas, such as habitats, to treat or prevent fungal infections in animals.
1 - 19 . (canceled)
20 . The method of claim 19 , wherein the animal is a bat, wherein the microbial infection comprises Pseudogymnoascus destructans.
21 . A method of automatically dispersing a liquid in aerosol form comprising:
receiving, by a computing device, one or more input parameters;
determining, by the computing device based on the input parameters, how long to run a nebulizer unit operably connected with the computing device to achieve a concentration of a compound in an airspace; and
running the nebulizer unit for the determined run time.
22 . The method of claim 21 , wherein the compound to be dispersed in aerosol form comprises essential oils, VOCs or VOC formulations.
23 . The method of claim 21 , wherein the input parameters include one or more of an off time for the nebulizer unit, a run time for the nebulizer unit, a start delay for the nebulizer unit, a volume of airspace where the nebulizer unit is to be used, an air turnover rate in the airspace, a barometric pressure in the airspace, a molecular weight of the compound in the reservoir, a desired concentration of the compound in the airspace, and how often to raise the airspace to the desired concentration.
24 . The method of claim 21 , wherein the determined run time is determined using at least in part an ideal gas law.
25 . The method of claim 21 , wherein the computing device executes computer-readable instructions to delay a start of the nebulizer unit; turn on the nebulizer unit for a time (T=Run Time); apply a conversion factor to the run time, T, to determine TConv, where the conversion factor is based on a temperature and voltage of a power source that provides power to the nebulizer unit; and, if TConv is less than run time T, then the nebulizer unit is turned on for an additional time period as determined by T−Tconv.
26 . The method of claim 21 , wherein the AAU is use to treating or preventing fungal infection in an animal.
27 . The method of claim 26 , wherein the animal is a bat, wherein the fungus comprises Pseudogymnoascus destructans.
28 . A method for treating or preventing fungal infection in an animal, comprising exposing the animal to a composition comprising one or more volatile organic compounds (VOCs) in a quantity sufficient to inhibit or reduce fungal growth in the animal.
29 . The method of claim 28 , wherein the VOC is selected from the group consisting of 2-ethyl-1-hexanol, benzaldehyde, benzothiazole, decanal, nonanal, and N,N-dimethyloctylamine.
30 . The method of claim 29 , wherein the composition comprises 2-ethyl-1-hexanol and benzaldehyde; 2-ethyl-1-hexanol and nonanal; 2-ethyl-1-hexanol and decanal; or 2-ethyl-1-hexanol and N,N-dimethyloctylamine.
31 . The method of claim 29 , wherein the composition comprises 2-ethyl-1-hexanol, benzaldehyde, and decanal.
32 . The method of claim 29 , wherein the composition comprises 2-ethyl-1-hexanol, nonanal, and decanal.
33 . The method of claim 28 , wherein the VOC is selected from the group consisting of propionoic acid, 2-nonanone, undecene, styrene, β-phenylethanol, and dimethyl sulfide.
34 . The method of claim 28 , wherein the animal is a bat, wherein the fungus comprises Pseudogymnoascus destructans.